CD19 CAR-T
B-cell Lymphoma
ClinicalActive (Study Published)
Key Facts
About BinDeBio
Chinese biotech group developing next-generation CAR-T and TCR-T cell therapies for cancer treatment.
View full company profileTherapeutic Areas
Other B-cell Lymphoma Drugs
| Drug | Company | Phase |
|---|---|---|
| CAR-T Response Model | Quibim | Research |
| VNX-103 | Vironexis Biotherapeutics | IND-Enabling |
| ELC-301 | Elicera Therapeutics | Phase I/II |